Geldmacher DS - Search Results

1

Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Gauthier S, Bodick N, Erzigkeit E, Feldman H, Geldmacher DS, Huff J, Mohs R, Orgogozo JM, Rogers S. Gauthier S, et al. Among authors: geldmacher ds. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:6-7. Alzheimer Dis Assoc Disord. 1997. PMID: 9305507 No abstract available.

2

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Mohs RC, et al. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S13-21. Alzheimer Dis Assoc Disord. 1997. PMID: 9236948

3

Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Post SG, Beerman B, Brodaty H, Gaines AW, Gauthier SG, Geldmacher DS, Hill S, Homma A, Rossor MN, Whitehouse PJ, Winblad B. Post SG, et al. Among authors: geldmacher ds. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:26-8. Alzheimer Dis Assoc Disord. 1997. PMID: 9305511 No abstract available.

4

Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Ferris SH, Lucca U, Mohs R, Dubois B, Wesnes K, Erzigkeit H, Geldmacher D, Bodick N. Ferris SH, et al. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:34-8. Alzheimer Dis Assoc Disord. 1997. PMID: 9305514 No abstract available.

5

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.

Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Schilling LP, et al. Mol Neurobiol. 2019 Jul;56(7):4916-4924. doi: 10.1007/s12035-018-1405-1. Epub 2018 Nov 9. Mol Neurobiol. 2019. PMID: 30414086

6

Accelerated functional brain aging in pre-clinical familial Alzheimer's disease.

Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, Poirier J, Vachon-Presseau E, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Dominantly Inherited Alzheimer Network (DIAN) Study Group; Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease (PREVENT-AD) Research Group. Gonneaud J, et al. Nat Commun. 2021 Sep 9;12(1):5346. doi: 10.1038/s41467-021-25492-9. Nat Commun. 2021. PMID: 34504080 Free PMC article.

7

Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females.

Wang YT, Therriault J, Servaes S, Tissot C, Rahmouni N, Macedo AC, Fernandez-Arias J, Mathotaarachchi SS, Benedet AL, Stevenson J, Ashton NJ, Lussier FZ, Pascoal TA, Zetterberg H, Rajah MN, Blennow K, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Wang YT, et al. Brain. 2024 Apr 4;147(4):1497-1510. doi: 10.1093/brain/awad397. Brain. 2024. PMID: 37988283 Free PMC article.

8

Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains.

Quesnel MJ, Labonté A, Picard C, Zetterberg H, Blennow K, Brinkmalm A, Villeneuve S, Poirier J; Alzheimer’s Disease Neuroimaging Initiative; PREVENT-AD Research Group. Quesnel MJ, et al. Brain. 2024 May 3;147(5):1680-1695. doi: 10.1093/brain/awad398. Brain. 2024. PMID: 37992295

9

Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL; Alzheimer's Disease Cooperative Study Group. Lu PH, et al. Neurology. 2009 Jun 16;72(24):2115-21. doi: 10.1212/WNL.0b013e3181aa52d3. Neurology. 2009. PMID: 19528519 Free PMC article. Clinical Trial.

10

The future is now: model-based clinical trial design for Alzheimer's disease.

Romero K, Ito K, Rogers JA, Polhamus D, Qiu R, Stephenson D, Mohs R, Lalonde R, Sinha V, Wang Y, Brown D, Isaac M, Vamvakas S, Hemmings R, Pani L, Bain LJ, Corrigan B; Alzheimer's Disease Neuroimaging Initiative; Coalition Against Major Diseases. Romero K, et al. Clin Pharmacol Ther. 2015 Mar;97(3):210-4. doi: 10.1002/cpt.16. Epub 2014 Dec 27. Clin Pharmacol Ther. 2015. PMID: 25669145 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters